Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer

Fabio Pomerri, Salvatore Pucciarelli, Isacco Maretto, Michela Zandon, Paola Del Bianco, Luca Amadio, Massimo Rugge, Donato Nitti, Pier C. Muzzio

Research output: Contribution to journalArticlepeer-review


Background: The aim of the study was to assess the accuracy of imaging techniques in predicting pathologic tumor (ypT), node (ypN) stages and the circumferential resection margin (ypCRM) status of rectal cancers after preoperative chemoradiotherapy (CRT). Methods: Using pelvic computed tomography (CT), magnetic resonance imaging (MRI), and endorectal ultrasound (ERUS), 90 consecutive patients with locally advanced mid-to-low rectal cancer were prospectively assessed. Postirradiation T and N stages and infiltration of the CRM, as assessed by CT, MRI and ERUS, were compared with histopathologic findings. Results: The accuracy of ypT staging was low, whatever the imaging technique used (37% by CT, 34% by MRI, and 27% by ERUS), the most frequent inaccuracy being overstaging. Imaging showed a good specificity and good negative predictive values (NPV) when mural staging was grouped into ypT ≤3 and ypT4 categories; in particular, ERUS achieved a 92% specificity and 95% NPV. CRM involvement was correctly predicted in 71% of patients by CT (74% specificity; 93% NPV) and in 85% by MRI (88% specificity; 95% NPV). The accuracy for nodal staging was 62%, 68%, and 65% by CT, MRI and ERUS, respectively; the corresponding NPV were 88%, 78%, and 76%. Conclusion: Current imaging techniques are inaccurate in restaging rectal cancer after CRT but are useful in predicting T ≤3 tumors, cases with negative nodes and tumor-free CRM. These findings may be of clinical relevance for planning less invasive surgery.

Original languageEnglish
Pages (from-to)56-64
Number of pages9
Issue number1
Publication statusPublished - Jan 2011

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer'. Together they form a unique fingerprint.

Cite this